Your browser doesn't support javascript.
loading
Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines.
Risma, Kimberly A; Edwards, Kathryn M; Hummell, Donna S; Little, Frederic F; Norton, Allison E; Stallings, Amy; Wood, Robert A; Milner, Joshua D.
Afiliación
  • Risma KA; Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio. Electronic address: Kimberly.Risma@cchmc.org.
  • Edwards KM; Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tenn.
  • Hummell DS; Division of Pediatric Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University School of Medicine, Nashville, Tenn.
  • Little FF; Division of Pulmonary, Allergy, Sleep and Critical Care Medicine, Department of Pediatrics, Boston University School of Medicine, Boston, Mass.
  • Norton AE; Division of Pediatric Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University School of Medicine, Nashville, Tenn.
  • Stallings A; Division of Pediatric Allergy and Immunology, Duke University Medical Center, Durham, NC.
  • Wood RA; Division of Pediatric Allergy and Immunology, Johns Hopkins University School of Medicine, Baltimore, Md.
  • Milner JD; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY.
J Allergy Clin Immunol ; 147(6): 2075-2082.e2, 2021 06.
Article en En | MEDLINE | ID: mdl-33857566
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: ARN Mensajero / Hipersensibilidad a las Drogas / Nanopartículas / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Anafilaxia / Lípidos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: ARN Mensajero / Hipersensibilidad a las Drogas / Nanopartículas / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Anafilaxia / Lípidos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2021 Tipo del documento: Article